Back to results
US 2016/0120962 A1Published application
Apobec3a as an anti-tumor agent
AssigneeInvectys
InventorsPierre LANGLADE DEMOYEN, Anna KOSTRZAK, Simon WAIN-HOBSON
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of a nucleic acid that comprises a sequence encoding an APOBEC3A protein, in preventing or treating a tumor in a patient.
Claims11
A protein for use in A method for preventing or treating a solid tumor in a patient, which method comprises administering the patient with a nucleic acid that comprises a sequence encoding an APOBEC3A protein, by injection at the tumor site.
Dependencies are inferred from the claim text.